title: Comparison of E-test with other conventional susceptibility testing methods for ciprofloxacin and gentamicin against gram negative enteric bacilli.
abstract: BACKGROUND
  Increasing antibiotic resistance in Gram negative bacteria has led to the need for a faster and reliable method for determining antimicrobial susceptibility testing. In a resource poor setting like ours, it's also important to look for methods that will be clinically and economically beneficial to the patient.
  
  
  OBJECTIVE
  This study was aimed at evaluating the Epsilometer test (E-test) and conventional methods for determining antimicrobial susceptibility of isolates of Gram-negative enteric bacteria to ciprofloxacin and gentamicin.
  
  
  METHODS
  Disc diffusion, E-test, broth dilution and agar dilution methods were performed on 54 bacterial isolates.
  
  
  RESULTS
  Using the E-test, 88.9% of bacterial isolates were resistant to ciprofloxacin, 92.6% were resistant using broth microdilution, 96.3% were resistant using agar dilution and 72.2% were resistant using disc diffusion. Minimum inhibitory concentration (MIC50) of isolates for gentamicin showed significant difference for all the techniques (p < 0.05) while MIC90 for gentamicin and MIC50 and MIC90 for ciprofloxacin for all the techniques had no significant difference (p > 0.05). Both E-test and broth dilution methods showed high levels of agreement (p > 0.05), there were low levels of agreement between E-test and agar dilution method (p < 0.05), especially at MIC50.
  
  
  CONCLUSIONS
  The E-test can therefore be considered a reliable method to determine antimicrobial susceptibility testing and it gives results which are at least as accurate as those obtained by the broth dilution method.
authors.affiliation: Department of Biomedical Sciences, College of Health Sciences, (Osogbo Campus), Ladoke Akintola University of Technology, Ogbomoso. olusogadave@yahoo.com
authors.forename: D O
authors.initials: DO
authors.lastname: Ogbolu
authors.forename: O A
authors.initials: OA
authors.lastname: Terry-Alli
authors.forename: O A
authors.initials: OA
authors.lastname: Daini
authors.forename: F A
authors.initials: FA
authors.lastname: Olabiyi
authors.forename: E A
authors.initials: EA
authors.lastname: Igharo
mesh_terms: D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D002939:Ciprofloxacin / Q000627:therapeutic use*; D004352:Drug Resistance, Microbial; D005839:Gentamicins / Q000627:therapeutic use*; D006090:Gram-Negative Bacteria / Q000187:drug effects*; D016905:Gram-Negative Bacterial Infections / Q000188:drug therapy*; D006801:Humans; D008826:Microbial Sensitivity Tests / Q000295:instrumentation / Q000379:methods*
chemical_list: D000900:Anti-Bacterial Agents; D005839:Gentamicins; D002939:Ciprofloxacin